Novavax Inc (NVAX)

NASDAQ HEALTHCARE
$9.21 +2.56% RSI 54 Neutral Add Alert

Moving Averages

SMA 200
$8.25
Price above

Company Profile

Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.56B
P/E Ratio
None
EPS
$-0.56
Beta
2.369
Dividend Yield
0.00%
52-Week High
$11.97
52-Week Low
$5.87

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 45.0
VRTX
Vertex Pharmaceuticals Inc
RSI 48.0
CRSP
CRISPR Therapeutics AG
RSI 47.0
MRNA
Moderna Inc
RSI 43.0
VKTX
Viking Therapeutics Inc
RSI 47.0
SRPT
Sarepta Therapeutics Inc
RSI 33.0
EDIT
Editas Medicine Inc
RSI 47.0
IOVA
Iovance Biotherapeutics Inc
RSI 62.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 53.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 42.0

Data last updated: May 12, 2026 at 8:21 AM EDT

Track NVAX for free

Get e-mail RSI alerts when Novavax Inc enters oversold or overbought territory. Free forever.

Add Alert